Cargando…
Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations
Introduction: Multiple Sclerosis (MS) is the most common immune-mediated chronic neurodegenerative disease of the central nervous system (CNS) affecting young people. This is due to the permanent disability, cognitive impairment, and the enormous detrimental impact MS can exert on a patient’s health...
Autores principales: | Biernacki, Tamás, Kokas, Zsófia, Sandi, Dániel, Füvesi, Judit, Fricska-Nagy, Zsanett, Faragó, Péter, Kincses, Tamás Zsigmond, Klivényi, Péter, Bencsik, Krisztina, Vécsei, László |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951485/ https://www.ncbi.nlm.nih.gov/pubmed/35328802 http://dx.doi.org/10.3390/ijms23063383 |
Ejemplares similares
-
Epidemiology of multiple sclerosis in Central Europe, update from Hungary
por: Biernacki, Tamás, et al.
Publicado: (2020) -
Proteomics in Multiple Sclerosis: The Perspective of the Clinician
por: Sandi, Dániel, et al.
Publicado: (2022) -
The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary
por: Biernacki, Tamás, et al.
Publicado: (2022) -
Contributing factors to health‐related quality of life in multiple sclerosis
por: Biernacki, Tamás, et al.
Publicado: (2019) -
Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy—Kynurenines Are Important Players
por: Sandi, Dániel, et al.
Publicado: (2021)